Previous close | 478.55 |
Open | 481.38 |
Bid | 484.51 x 800 |
Ask | 486.00 x 800 |
Day's range | 472.32 - 487.45 |
52-week range | 383.12 - 553.29 |
Volume | |
Avg. volume | 3,207,233 |
Market cap | 455.698B |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | 26.59 |
EPS (TTM) | 18.27 |
Earnings date | 15 Jul 2022 |
Forward dividend & yield | 5.80 (1.21%) |
Ex-dividend date | 11 Mar 2022 |
1y target est | 568.52 |
The next-generation of Align Technology's (ALGN) advanced patient communication tool will help patients see their potential new smile after Invisalign treatment.
LabCorp's (LH) new assay is claimed to have shown a demonstrable clinical advantage in patients suffering from melanoma.
Globus Medical's (GMED) Excelsius3D, when combined with ExcelsiusGPS, facilitates greater implant placement accuracy, lowers radiation exposure and reduces operative times.